Previous close | 18.15 |
Open | 18.17 |
Bid | 17.90 x 1200 |
Ask | 17.94 x 1200 |
Day's range | 17.68 - 18.27 |
52-week range | 13.82 - 27.95 |
Volume | |
Avg. volume | 395,239 |
Market cap | 842.292M |
Beta (5Y monthly) | 2.41 |
PE ratio (TTM) | 35.39 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.04 (0.22%) |
Ex-dividend date | 03 May 2024 |
1y target est | N/A |
Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Core's operating income was $8,600,000, with diluted earnings per share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $14,900,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19. During the first quarter of 2024, the Company recorded: 1) appr
Core Laboratories (NYSE: "CLB") will broadcast its first quarter 2024 conference call over the Internet at 7:30 a.m. CDT / 8:30 a.m. EDT on April 25, 2024.
Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported fourth quarter 2023 revenue of $128,200,000. Core's operating income was $14,600,000, with diluted earnings per share ("EPS") of $0.14, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $15,000,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19. The Company's fourth quarter 2023 effective tax rate was nega